FAM76A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 9.7233998630486E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.04460000053209E-07 |
Normal-vs-Stage2 |
2.2476000000049E-06 |
Normal-vs-Stage3 |
2.96630053853164E-10 |
Normal-vs-Stage4 |
1.45800038708899E-10 |
Stage1-vs-Stage2 |
3.721400E-01 |
Stage1-vs-Stage3 |
3.175700E-03 |
Stage1-vs-Stage4 |
1.362990E-04 |
Stage2-vs-Stage3 |
2.291000E-01 |
Stage2-vs-Stage4 |
2.898200E-02 |
Stage3-vs-Stage4 |
2.698800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.15139997536318E-09 |
Normal-vs-AfricanAmerican |
3.10390000002325E-06 |
Normal-vs-Asian |
4.2932000000051E-05 |
Caucasian-vs-AfricanAmerican |
4.475200E-01 |
Caucasian-vs-Asian |
1.535580E-01 |
AfricanAmerican-vs-Asian |
1.160180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.56209547706044E-11 |
Normal-vs-Female |
1.80309999999739E-05 |
Male-vs-Female |
3.610600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.21729999968956E-07 |
Normal-vs-Extreme_Weight |
6.46860000008687E-08 |
Normal-vs-Obese |
2.24999999742792E-08 |
Normal-vs-Extreme_Obese |
5.165300E-04 |
Normal_Weight-vs-Extreme_Weight |
5.740400E-01 |
Normal_Weight-vs-Obese |
4.277000E-01 |
Normal_Weight-vs-Extreme_Obese |
6.512800E-01 |
Extreme_Weight-vs-Obese |
8.107800E-01 |
Extreme_Weight-vs-Extreme_Obese |
8.898200E-01 |
Obese-vs-Extreme_Obese |
9.807800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.91900000001688E-06 |
Normal-vs-Age(41-60Yrs) |
3.47850000004257E-06 |
Normal-vs-Age(61-80Yrs) |
8.22180101778258E-11 |
Normal-vs-Age(81-100Yrs) |
1.5963299999977E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.073550E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.049200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.259400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.349800E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.614750E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.910000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.13100000032063E-07 |
Normal-VS-Type2 PRCC |
1.1303957769826E-11 |
Normal-VS-KIRP CIMP |
4.97960006562437E-10 |
Normal-VS-Unclassified PRCC |
1.51936999999158E-05 |
Type1 PRCC-VS-Type2 PRCC |
7.95960000000706E-05 |
Type1 PRCC-VS-KIRP CIMP |
6.00419999999824E-05 |
Type1 PRCC-VS-Unclassified PRCC |
4.033000E-01 |
Type2 PRCC-VS-KIRP CIMP |
5.053900E-02 |
Type2 PRCC-VS-Unclassified PRCC |
5.302500E-02 |
KIRP CIMP-VS-Unclassified PRCC |
1.475350E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.52150514409755E-11 |
Normal-vs-N1 |
3.32669447544731E-11 |
Normal-vs-N2 |
5.203400E-04 |
N0-vs-N1 |
1.051210E-01 |
N0-vs-N2 |
4.053400E-01 |
N1-vs-N2 |
9.169600E-01 |
|
|